Skip to Main Content
MyYSM
YSM Home

INFORMATION FOR

Adjunct Faculty

Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.

Adjunct rank details

John Seibyl, MD

Professor Adjunct

About

Titles

Professor Adjunct

Biography

John Seibyl, M.D. is Distinguished Scientist and Chairman of the Board of the Institute for Neurodegenerative Disorders (IND) in New Haven, CT. Prior to IND, Dr. Seibyl was Chief, Section of Nuclear Medicine and Associate Professor of Diagnostic Radiology and Psychiatry, Yale University School of Medicine. He is a pioneer in the use of Dopamine Transporter (DaT) SPECT imaging for the assessment of Parkinson’s disease and related disorders. He serves on the editorial board of the European Journal of Nuclear Medicine and is a frequent reviewer for top-tier nuclear imaging journals. He serves on international panels for his work in neurodegenerative disease imaging. He recently re-joined Yale as Adjunct Professor of Neurology.

Last Updated on August 10, 2026.

Appointments

Other Departments & Organizations

Education & Training

MD
Case Western Reserve Univ (1986)

Research

Research at a Glance

Yale Co-Authors

Frequent collaborators of John Seibyl's published research.

Publications

2026

  • Joint EANM/SNMMI recommendations on the use of Tau PET imaging in Alzheimer's disease
    Brendel M, Kuo P, Brumberg J, Doré V, Drzezga A, Garibotto V, Leuzy A, Mathoux G, Meyer P, Moscoso A, Ossenkoppele R, Pascoal T, Smith R, Seibyl J, van de Giessen E, Van Weehaeghe D, Vermeiren M, Villemagne V, Esfahani S, Barthel H, Committee T, Brendel M, Cecchin D, Fernandez P, Guedj E, Tolboom N, Traub-Weidinger T, Van Weehaeghe D, Verger A, Yakushev I. Joint EANM/SNMMI recommendations on the use of Tau PET imaging in Alzheimer's disease. The EANM Journal 2026, 3: 100214. DOI: 10.1016/j.eanmj.2026.100214.
    Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
  • Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease
    Gonzalez‐Latapi P, Gochanour C, Choi S, Cho H, Caspell‐Garcia C, Coffey C, Brumm M, Lafontant D, Xiao Y, Tropea T, Seibyl J, Tanner C, Venuto C, Kieburtz K, Chahine L, Poston K, Siderowf A, Marek K, Simuni T, Initiative T. Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease. Annals Of Clinical And Translational Neurology 2026 PMID: 41808287, DOI: 10.1002/acn3.70323.
    Peer-Reviewed Original Research
  • Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale
    Fan Z, Searle G, Rizzo G, Albani J, Cella P, Comley R, Klein G, Passamonti L, Salinas C, Schwarz A, Iaccarino L, Tamagnan G, Eberling J, Marek K, Seibyl J, Gunn R, Marek K, Tanner C, Simuni T, Siderowf A, Galasko D, Chahine L, Coffey C, Merchant K, Poston K, Dobkin R, Foroud T, Mollenhauer B, Weintraub D, Brown E, Kieburtz K, Frasier M, Sherer T, Chowdhury S, Alcalay R, Videnovic A, Tosun‐Turgut D, Poewe W, Bressman S, Hammer J, James R, Riley E, Seibyl J, Shaw L, Standaert D, Mantri S, Dahodwala N, Schwarzschild M, Marras C, Fernandez H, Shoulson I, Rowbotham H, Casalin P, Trenkwalder C, Sherer T, Chowdhury S, Frasier M, Eberling J, Kopil K, O'Grady A, Kuhl M, Kirsch L, Willson T, Adler C, Alcalay R, Amara A, Barone P, Bloem B, Bressman S, Brockmann K, Brüggemann N, Chahine L, Chou K, Dahodwala N, Espay A, Factor S, Fernandez H, Fullard M, Galasko D, Hauser R, Hogarth P, Hu S, Hu M, Isaacson S, Klein C, Krueger R, Lew M, Mari Z, Marras C, Martí M, McFarland N, Mestre T, Mollenhauer B, Moukheiber E, Noyce A, Okubadejo N, O'Shea S, Pahwa R, Pavese N, Poewe W, Postuma R, Riboldi G, Ruffrage L, Martinez J, Russell D, Saint‐Hilaire M, Santos N, Schlett47 W, Schneider R, Shill H, Shprecher D, Simuni T, Standaert D, Stefanis L, Tai Y, Tanner C, Tarakad A, PhD34 E, Videnovic A, Ainscough S, Blair C, Botting E, Chung I, Clark K, Croitoru I, DeLano K, Egner I, Esha F, Eshel M, Ferrari F, Foster V, Garrido A, Grümmer M, Herrera B, Hilt E, Huntzinger C, James R, Kausar F, Koros C, Krasowski60 Y, Le D, Liu Y, Marques T, Santana H, Mosovsky S, Mule J, Ng P, O'Brien L, Ogunleye A, Ojo O, Onyinanya O, Pennente L, Perrotti R, Pileggi M, Ramachandran A, Raymond D, Razzaque J, Reddie S, Ribb K, Rizer K, Rodriguez J, Roman S, Sanchez C, Simonet C, Singh A, Sittig E, Sommerfeld B, Stovall A, Stubbeman B, Valenzuela A, Wandell C, Willeke D, Williams K, Wubuli D. Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale. Annals Of Neurology 2026, 99: 949-963. PMID: 41556298, PMCID: PMC13011789, DOI: 10.1002/ana.78116.
    Peer-Reviewed Original Research

2025

2024

2023

See All Publications